Skip to main content
TipRanks
Go Ultimate75% OFF

Sonoma Pharmaceuticals (O8Z) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Sonoma Pharmaceuticals has a market cap or net worth of EUR 3.85M. The enterprise value is EUR 2.28M.

Market Cap
EUR 3.85M
Enterprise Value
EUR 2.28M

Share Statistics

Sonoma Pharmaceuticals has 5,061,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
5,061,593
Owned by Insiders
6.99%
Owned by Institutions
1.47%

Financial Efficiency

Sonoma Pharmaceuticals’s return on equity (ROE) is -1.03 and return on invested capital (ROIC) is -24.05%.

Return on Equity (ROE)
-1.03
Return on Assets (ROA)
-0.23
Return on Invested Capital (ROIC)
-24.05%
Return on Capital Employed (ROCE)
-0.27
Revenue Per Employee
1.95M
Profits Per Employee
-317.50K
Employee Count
10
Asset Turnover
1.40
Inventory Turnover
3.32

Valuation Ratios

The current PE Ratio of Sonoma Pharmaceuticals is -0.91. Sonoma Pharmaceuticals’s PEG ratio is -0.01.

PE Ratio
-0.91
PS Ratio
0.18
PB Ratio
0.61
Price to FCF
-1.50
Price to Operating Cash Flow
-1.52
PEG Ratio
-0.01

Income Statement

In the last 12 months, Sonoma Pharmaceuticals had revenue of 19.53M and earned -3.17M in profits. Earnings per share was -1.89.

Revenue
19.53M
Gross Profit
7.42M
Operating Income
-2.46M
Pretax Income
-3.42M
Net Income
-3.17M
EBITDA
-2.32M
Earnings Per Share (EPS)
-1.89

Cash Flow

In the last 12 months, operating cash flow was -2.67M and capital expenditures -120,000, giving a free cash flow of -2.79M billion.

Operating Cash Flow
-2.67M
Free Cash Flow
-2.79M
Free Cash Flow per Share
-0.57

Dividends & Yields

Sonoma Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-66.52%
Earnings Yield
-44.19%

Stock Price Statistics

Beta
―
52-Week Price Change
0.00%
50-Day Moving Average
2.69
200-Day Moving Average
2.69
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Sonoma Pharmaceuticals upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Feb 16, 2027
Ex-Dividend Date
―

Financial Position

Sonoma Pharmaceuticals as a current ratio of 2.50, with Debt / Equity ratio of 27.21%

Current Ratio
2.50
Quick Ratio
1.75
Debt to Market Cap
0.06
Net Debt to EBITDA
0.67
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Sonoma Pharmaceuticals has paid -244.00K in taxes.

Income Tax
-244.00K
Effective Tax Rate
0.07

Enterprise Valuation

Sonoma Pharmaceuticals EV to EBITDA ratio is -0.20, with an EV/FCF ratio of -0.07.

EV to Sales
0.01
EV to EBITDA
-0.20
EV to Free Cash Flow
-0.07
EV to Operating Cash Flow
-0.07

Balance Sheet

Sonoma Pharmaceuticals has EUR 4.61M in cash and marketable securities with EUR 602.00K in debt, giving a net cash position of EUR 4.01M billion.

Cash & Marketable Securities
EUR 4.61M
Total Debt
EUR 602.00K
Net Cash
EUR 4.01M
Net Cash Per Share
EUR 0.79
Tangible Book Value Per Share
EUR 1.35

Margins

Gross margin is 39.23%, with operating margin of -3.32%, and net profit margin of -7.65%.

Gross Margin
39.23%
Operating Margin
-3.32%
Pretax Margin
-5.93%
Net Profit Margin
-7.65%
EBITDA Margin
-4.00%
EBIT Margin
-4.55%